BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 3, 2026
Home » Authors » Mark McCarty

Articles by Mark McCarty

Washington roundup: FDA publishes draft guidance for enteral luer lock connectors

July 30, 2012
By Mark McCarty

Washington roundup: Draft of first-to-file patent rules may alter provisionals

July 27, 2012
By Mark McCarty
The U.S. Patent and Trademark Office has issued a draft of rules for the first-to-file provisions found in the America Invents Act of 2011 (AIA), and among the more interesting items found in the draft is a provision stating that if an inventor wishes to discredit a publication addressing prior art by someone other than the inventor or inventors, the patent applicant will have to file an affidavit that demonstrates that the patent applied for is virtually identical to the article mentioned in the applicant's prior disclosure.
Read More

Washington roundup: CBO: Lower Medicaid spending saves $84B, but problems remain

July 26, 2012
By Mark McCarty

Washington roundup: FTC commissioner sees problem in patents for standard-setting tech

July 25, 2012
By Mark McCarty

Washington roundup: Burgess inks doc fix extension bill, but offsets not spelled out

July 24, 2012
By Mark McCarty

Myriad at CAFC: Three points to remember

July 23, 2012
By Mark McCarty
The July 20 hearing at the Court of Appeals for the Federal Circuit addressing the Myriad case did not last a terribly long time, but there were a few object lessons to take away. We last visited this situation shortly after the Supreme Court decision in Prometheus v Mayo, when I opined that there might not be much reason to hit the panic button, and I have to say I didn’t hear much on July 20 to change my mind. But who can say for certain? After all, who’d have guessed at the 9-0 outcome at the Supreme Court (a.k.a.,...
Read More

Washington roundup: CAFC judges exhibit no drift in respective views of Myriad

July 23, 2012
By Mark McCarty

Washington roundup: Argentum under new ownership, yanks site subject of FDA warning

July 20, 2012
By Mark McCarty

Washington roundup: Emphasis on primary care holds despite clashes over SGR pay-go

July 19, 2012
By Mark McCarty

Washington roundup: FDA counsel's office said to have authorized surveillance

July 18, 2012
By Mark McCarty
Previous 1 2 … 426 427 428 429 430 431 432 433 434 … 579 580 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 2, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing